House Rules Committee Ranking Member Jim McGovern (D-Mass.) is aggressively whipping against a bill scheduled for a floor vote this week that would ban biotech companies in the United States that are affiliated with the Chinese Communist Party.
Premium
September 09, 2024
Jim McGovern leads whip effort against China bill
Presented by AstraZeneca
The 340B program was created to help patients. Instead, it’s helping hospitals earn massive profits. The 340B Rebate Model Pilot uses rapid verification of existing data to prevent duplicate discounts, strengthening program transparency and efficiency. Urge HHS to implement the Rebate Model Pilot and ensure 340B functions as intended. Get the facts.
Editorial photos provided by Getty Images. Political ads courtesy of AdImpact.
Presented by AstraZeneca
The 340B program is supposed to help vulnerable patients—but without strong safeguards, it’s siphoning away funds that could be used for free and charitable medicine. The 340B Rebate Model Pilot improves program integrity, preventing duplicate discounts and strengthening accountability. Urge HHS to implement the pilot today. Learn why it matters.